Pure Global
NCT06015958

Probiotic Toothpaste to Assess Microbial Colonization

Colonisation Efficacy of Streptococcus Salivarius M18 Toothpaste
BLIS Technologies Limited·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Microbial Colonization
Drug/Device/Intervention
Streptococcus salivarius M18 toothpaste (1 million cfu)
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
BLIS Technologies Limited
Location
Dunedin, New Zealand
Timeline & enrollment
Phase
N/A
Start date
Oct 01, 2023
End date
Feb 28, 2024
Enrollment
20 participants
Primary outcome

Change in Microbial colonization from baseline (Day 0) to 1 hour,Change in Microbial colonization from baseline (Day 0) to 8 hours,Change in Microbial colonization from baseline (Day 0) to 24 hours,Change in Microbial colonization from baseline (Day 0) to 8 hours post last dose

Summary

The aim of this study is to evaluate the colonization efficacy of probiotic toothpastes in
 healthy adults

ICD-10 classifications
Bacterial infection of unspecified siteOther bacterial infections of unspecified siteBacterial, viral and other infectious agentsCholeraOther specified bacterial intestinal infections
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06015958
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06015958 through Pure Global AI's free database. This phase not specified trial is sponsored by BLIS Technologies Limited and is currently Not yet recruiting. The study focuses on Microbial Colonization. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.